Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy-Reference-Cited by-同舟云学术

Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy

Author:

Kitamura Hidemitsu¹^ORCID,Ohno Yosuke¹²,Toyoshima Yujiro¹²,Ohtake Junya¹,Homma Shigenori²,Kawamura Hideki²,Takahashi Norihiko²,Taketomi Akinobu²

Affiliation:

1. Division of Functional Immunology Section of Disease Control Institute for Genetic Medicine Hokkaido University Sapporo Japan

2. Department of Gastroenterological Surgery I Hokkaido University Graduate School of Medicine Sapporo Japan

Funder

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Hokkaido University

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

Reference70 articles.

3. Peptide vaccines in cancer‐old concept revisited;Kumai T;Curr Opin Immunol,2016

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献